Neonatal hTSH FEIA Plus
Accurate neonatal thyroid screening for early detection of congenital hypothyroidism.

Overview
The Labsystems Diagnostics Neonatal hTSH FEIA Plus is a fluorometric enzyme immunoassay designed for the quantitative determination of human thyroid-stimulating hormone (hTSH) in dried blood spot samples. It serves as a primary screening test for congenital hypothyroidism (CH) in newborns, enabling early diagnosis and timely intervention to prevent developmental complications. The assay elutes hTSH from dried blood disks and forms a specific sandwich complex between two antibodies—one immobilized on the solid phase and another labeled with horseradish peroxidase (HRP). The resulting fluorescence signal is directly proportional to the hTSH concentration, ensuring reliable and reproducible results.

Features
- High analytical sensitivity for precise detection of low hTSH levels
- Reliable quantitation from dried blood spot samples
- Fluorometric enzyme immunoassay for consistent and stable performance
- Compatible with Labsystems Diagnostics’ neonatal screening platforms
- Optimized assay design for easy workflow integration in newborn screening laboratories
Technical Specifications
- Format : 10 solid plates / 960 wells
- Catalogue Number : 6199880
Performance & Applications
Performance
- Minimal background ensuring clean and accurate readings
- Excellent stability across assay runs and conditions
- Strong correlation with CDC reference samples
- Calibrated against international standards (WHO and ISNS) for globally comparable results
Applications
- Primary neonatal screening for congenital hypothyroidism (CH)
- Routine use in public health laboratories and hospital-based screening centers
